Finance

Lists
000538:SHE
Yunnan Baiyao Group Co Ltd
CN¥53,08
+0,34%
(+0,18) 1D
16 ຕ.ລ., 15 ໂມງ 4 ນາທີ 30 ວິນາທີ GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000538...
Open
CN¥52,89
High
CN¥53,66
Low
CN¥52,52
Mkt. cap
94,39 ຕື້
Avg. vol.
7,52 ລ້ານ
Volume
12,92 ລ້ານ
Dividend
4,94%
Quarterly dividend
CN¥0,66
Ex-dividend date
30 ມ.ສ. 2026
P/E ratio
18,14
52-wk high
CN¥58,20
52-wk low
CN¥46,29
EPS
CN¥2,93
Shares outstanding
1,78 ຕື້
No. of employees
9 ພັນ
Open
CN¥52,89
High
CN¥53,66
Low
CN¥52,52
Mkt. cap
94,39 ຕື້
Avg. vol.
7,52 ລ້ານ
Volume
12,92 ລ້ານ
Dividend
4,94%
Quarterly dividend
CN¥0,66
Ex-dividend date
30 ມ.ສ. 2026
P/E ratio
18,14
52-wk high
CN¥58,20
52-wk low
CN¥46,29
EPS
CN¥2,93
Shares outstanding
1,78 ຕື້
No. of employees
9 ພັນ
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
28 ນາທີກ່ອນ
What AAON Bears Saw Before The Fall
Trefis
Trefis
·
29 ນາທີກ່ອນ
1 S&P 500 Stock Hit A 52-Week Low On Friday
Profile
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products. The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species". As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
About Yunnan Baiyao Group Co Ltd
CEO-
Employees9,29 ພັນ
Founded1902
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
9,40 ຕື້
10,53 ຕື້
11,60 ຕື້
10,28 ຕື້
Cost of goods sold
6,70 ຕື້
7,85 ຕື້
8,05 ຕື້
7,28 ຕື້
Cost of revenue
6,70 ຕື້
7,85 ຕື້
8,05 ຕື້
7,28 ຕື້
Research and development expenses
79,10 ລ້ານ
115,55 ລ້ານ
76,79 ລ້ານ
112,78 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,39 ຕື້
2,37 ຕື້
1,28 ຕື້
1,50 ຕື້
Operating expense
1,33 ຕື້
2,67 ຕື້
1,44 ຕື້
1,64 ຕື້
Total operating expenses
8,03 ຕື້
10,52 ຕື້
9,48 ຕື້
8,92 ຕື້
Operating income
1,37 ຕື້
12,79 ລ້ານ
2,12 ຕື້
1,36 ຕື້
Other non operating income
-43,28 ລ້ານ
135,88 ລ້ານ
-17,44 ລ້ານ
37,87 ລ້ານ
EBT including unusual items
1,38 ຕື້
428,17 ລ້ານ
2,36 ຕື້
1,92 ຕື້
EBT excluding unusual items
1,47 ຕື້
233,79 ລ້ານ
2,35 ຕື້
1,74 ຕື້
Income tax expense
238,66 ລ້ານ
27,40 ລ້ານ
330,30 ລ້ານ
255,01 ລ້ານ
Effective tax rate
17,25%
6,40%
13,99%
13,27%
Other operating expenses
-18,86 ລ້ານ
129,96 ລ້ານ
6,54 ລ້ານ
116,66 ລ້ານ
Net income
1,14 ຕື້
376,37 ລ້ານ
2,04 ຕື້
1,66 ຕື້
Net profit margin
12,18%
3,57%
17,56%
16,18%
Earnings per share
0,61
0,18
1,10
0,87
Interest and investment income
136,98 ລ້ານ
107,27 ລ້ານ
253,40 ລ້ານ
367,65 ລ້ານ
Interest expense
-4,39 ລ້ານ
-8,83 ລ້ານ
-5,09 ລ້ານ
-5,15 ລ້ານ
Net interest expenses
132,58 ລ້ານ
98,43 ລ້ານ
248,31 ລ້ານ
362,50 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
1,42 ຕື້
70,91 ລ້ານ
2,18 ຕື້
1,43 ຕື້
Gain or loss from assets sale
2,26 ລ້ານ
-8,17 ລ້ານ
-
-3,05 ພັນ
AI content may include mistakes. Learn more
ແອັບຂອງ Google